what is noom glp-1 companion Launches Microdose Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program Noom: Lose weight and keep

This brief highlights how the financialized business model perpetuates health inequities that will disproportionately impact Black Americans and other marginalized populations who face higher rates of obesity and diabetes yet remain underrepresented in access to GLP-1 therapies

Examples of these include semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound)

In: FeingoldKRAnawaltBBlackmanMRBoyceAChrousosGCorpasEet al, editors

The SURMOUNT-1 trial on tirzepatide demonstrated even greater outcomes, with patients losing 1520% of body weight at higher doses

Ro is among the telehealth companies working to expedite that process by helping consumers find coverage options, treatment plans, and a provider that is right for their needs and goals